Search - tctmd.com

Displaying 981 - 1000 of 1342

Sort: Relevancy | Date

PORTICO I Postapproval Registry Outside the US Offers ‘Teaser’ for Pivotal Trial

Shelley Wood

June 23, 2018

Presentation The Structural Heart Disease Summit 2018

The Vancouver Minimalist Clinical Care Pathway: Updates from the 3M Trial and Evolution to BENCHMARK

Presenter: Vinod H. Thourani, John G. Webb, David A. Wood

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

The Self-Expanding Single-Operator CENTERA TAVR System: Clinical Data and Plans for the US Pivotal Trial

Presenter: Martin B. Leon

June 22, 2018

News Conference News The Structural Heart Disease Summit 2018

Will Percutaneous Mitral Repair Catch Up or Surpass Surgery? Experts Make Their Predictions

Shelley Wood

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Status Update of the EARLY TAVR Trial Asymptomatic Severe AS Patients

Presenter: Howard C. Herrmann, Allan Schwartz, Philippe Genereux

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Status Update of the TAVR UNLOAD Trial Moderate AS Patients With Reduced Ejection Fraction

Presenter: Howard C. Herrmann, Allan Schwartz, Nicolas M. Van Mieghem

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Will the Randomized Trials of MitraClip in Secondary MR Show Substantial Clinical Benefit? YES!

Presenter: Scott Lim

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Will the Randomized Trials of MitraClip in Secondary MR Show Substantial Clinical Benefit? NO!

Presenter: Francesco Maisano

June 22, 2018

News Conference News The Structural Heart Disease Summit 2018

Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR?

Shelley Wood

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Trialign Pioneering Work: Technology and Clinical Updates

Presenter: Christopher U. Meduri

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

MitraClip Updates I: Recent Clinical Trial Data and Current OUS Patient Selection Criteria

Presenter: Anthony N. DeMaria, Karl-Heinz Kuck, Anita Asgar

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

NOTION 1 - Five-Year FU and Notion 2 - Young & Low-Risk

Presenter: Lars Sondergaard

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

UK All-Comers

Presenter: Neil E. Moat

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Evolut R Low-Risk

Presenter: Jeffrey J. Popma

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Partner 3 Low-Risk

Presenter: Martin B. Leon

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials

Presenter: Eberhard Grube, Tamim Nazif

June 21, 2018

News Daily News

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Michael O'Riordan

June 20, 2018

News Daily News

Percutaneous Edge-to-Edge Repair for Tricuspid Regurgitation: Some Successes, Some Caveats

Shelley Wood

June 18, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2018

Caitlin E. Cox

June 01, 2018

News Conference News EuroPCR 2018

Real-World Sapien 3 Results Match Trial Experience in Intermediate-Risk Patients

Caitlin E. Cox

May 25, 2018

Advertisement

PORTICO I Postapproval Registry Outside the US Offers ‘Teaser’ for Pivotal Trial

The Vancouver Minimalist Clinical Care Pathway: Updates from the 3M Trial and Evolution to BENCHMARK

The Self-Expanding Single-Operator CENTERA TAVR System: Clinical Data and Plans for the US Pivotal Trial

Will Percutaneous Mitral Repair Catch Up or Surpass Surgery? Experts Make Their Predictions

Status Update of the EARLY TAVR Trial Asymptomatic Severe AS Patients

Status Update of the TAVR UNLOAD Trial Moderate AS Patients With Reduced Ejection Fraction

Will the Randomized Trials of MitraClip in Secondary MR Show Substantial Clinical Benefit? YES!

Will the Randomized Trials of MitraClip in Secondary MR Show Substantial Clinical Benefit? NO!

Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR?

Trialign Pioneering Work: Technology and Clinical Updates

MitraClip Updates I: Recent Clinical Trial Data and Current OUS Patient Selection Criteria

NOTION 1 - Five-Year FU and Notion 2 - Young & Low-Risk

UK All-Comers

Evolut R Low-Risk

Partner 3 Low-Risk

Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Percutaneous Edge-to-Edge Repair for Tricuspid Regurgitation: Some Successes, Some Caveats

TCTMD’s Top 10 Most Popular Stories for May 2018

Real-World Sapien 3 Results Match Trial Experience in Intermediate-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content